SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-004478
Filing Date
2022-01-14
Accepted
2022-01-14 17:12:56
Documents
12
Period of Report
2022-01-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm222651d2_8k.htm   iXBRL 8-K 25787
  Complete submission text file 0001104659-22-004478.txt   200624

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nrbo-20220114.xsd EX-101.SCH 3048
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nrbo-20220114_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nrbo-20220114_pre.xml EX-101.PRE 22605
6 EXTRACTED XBRL INSTANCE DOCUMENT tm222651d2_8k_htm.xml XML 3732
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 22532646
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences